EVOME MEDICAL TECHNOLOGIES INC. Quarterly Net Cash Provided by (Used in) Financing Activities in CAD from Q2 2021 to Q1 2023

Taxonomy & unit
us-gaap: CAD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Evome Medical Technologies Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from Q2 2021 to Q1 2023.
  • Evome Medical Technologies Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was CA$2.58M, a 43.4% decline year-over-year.
  • Evome Medical Technologies Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was CA$825K.
  • Evome Medical Technologies Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was CA$3.94M, a 27.5% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (CAD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 2.58M -1.97M -43.4% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q2 2022 -193K +154K +44.4% Mar 1, 2022 May 31, 2022 10-Q 2022-07-15
Q1 2022 4.55M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q2 2021 -347K Mar 1, 2021 May 31, 2021 10-Q 2022-07-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.